Clinical trial
Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid…
NCT00006019 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00006019 |
|---|---|
| Title | Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer |
| Official title | Pilot Study of Sodium Phenylbutyrate Plus Azacytidine |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Lung Cancer, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Prostate Cancer |
| Intervention type | Drug |
| Interventions | azacitidine, sodium phenylbutyrate |
| Start date | May 1, 2000 |
| Completion | Aug 1, 2003 |
| First posted | Aug 29, 2003 |
| Last update posted | Jun 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: